GLASSIA
GLASSIA
Approved
DIN Number
02522438
Drug Class
Human
Market Date
Jan 2, 2024
Company
HC
takeda canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02522438
AIG Number0120888004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02AB02 ALFA1 ANTITRYPSIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ALPHA1-PROTEINASE INHIBITOR (HUMAN)Active
Strength: 1000 MG / 50 ML
Monograph: ALPHA1-PROTEINASE INHIBITOR (HUMAN)